At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Stephen M. Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses the clinical development of combination approaches with immune checkpoint inhibitors for the treatment of patients with non-Hodgkin and Hodgkin lymphoma. Challenges and directions for future trials with this approach are also proposed.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates